Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | AMRXAmneal Pharmaceuticals, Inc.FY2025 · Dec |
|---|---|
| Revenue | $3.02B |
| Revenue, yoy | +8.0% |
| Net income | $72.06M |
| Net income, yoy | +161.6% |
| Net margin | 2.4% |
| Free cash flow | $269.93M |
| FCF margin | 8.9% |
| EPS, diluted | $0.22 |
Add another company.